1887

Microbial Genomics logo

Volume 8, Issue 2

Genomic and phenotypic analyses of diverse non-clinical strains reveals strain-specific virulence and resistance capacity Open Access

Abstract

is a critically important pathogen known for its widespread antibiotic resistance and ability to persist in hospital-associated environments. Whilst the majority of infections are hospital-acquired, infections from outside the hospital have been reported with high mortality. Despite this, little is known about the natural environmental reservoir(s) of and the virulence potential underlying non-clinical strains. Here, we report the complete genome sequences of six diverse strains isolated from environments such as river, soil, and industrial sites around the world. Phylogenetic analyses showed that four of these strains were unrelated to representative nosocomial strains and do not share a monophyletic origin, whereas two had sequence types belonging to the global clone lineages GC1 and GC2. Further, the majority of these strains harboured genes linked to virulence and stress protection in nosocomial strains. These genotypic properties correlated well with virulence phenotypic assays testing resistance to abiotic stresses, serum survival, and capsule formation. Virulence potential was confirmed with most environmental strains able to effectively kill greater wax moth larvae. Using phenomic arrays and antibiotic resistance profiling, environmental and nosocomial strains were shown to have similar substrate utilisation patterns although environmental strains were distinctly more sensitive to antibiotics. Taken together, these features of environmental strains suggest the existence of a strain-specific distinct gene pools for niche specific adaptation. Furthermore, environmental strains appear to be equally virulent as contemporary nosocomial strains but remain largely antibiotic sensitive.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Acinetobacter baumannii , environmental , Galleria mellonella , genome sequence , MLST , niche adaptation , resistance and virulence
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000765
2022-02-15
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/mgen/8/2/mgen000765.html?itemId=/content/journal/mgen/10.1099/mgen.0.000765&mimeType=html&fmt=ahah

References

  1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–582 [View Article] [PubMed]
     [Google Scholar]
  2. Roca I, Espinal P, Vila-Farrés X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012; 3:148 [View Article] [PubMed]
     [Google Scholar]
  3. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59:1210–1215 [View Article] [PubMed]
     [Google Scholar]
  4. Kochar M, Crosatti M, Harrison EM, Rieck B, Chan J et al. Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain. Antimicrob Agents Chemother 2012; 56:1845–1853 [View Article] [PubMed]
     [Google Scholar]
  5. Douraghi M, Kenyon JJ, Aris P, Asadian M, Ghourchian S et al. Accumulation of antibiotic resistance genes in carbapenem-resistant Acinetobacter baumannii isolates belonging to lineage 2, global clone 1, from outbreaks in 2012-2013 at a tehran burns hospital. mSphere 2020; 5:e00164-20 [View Article]
     [Google Scholar]
  6. Holt K, Kenyon JJ, Hamidian M, Schultz MB, Pickard DJ et al. Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant Acinetobacter baumannii global clone 1. Microb Genom 2016; 2:e000052 [View Article] [PubMed]
     [Google Scholar]
  7. WHO WHO publishes list of bacteria for which new antibiotics are urgently needed. WHO Media centre 2017
     [Google Scholar]
  8. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197:1079–1081 [View Article] [PubMed]
     [Google Scholar]
  9. Mortensen E, Trivedi KK, Rosenberg J, Cody SH, Long J et al. Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care. Infect Control Hosp Epidemiol 2014; 35:406–411 [View Article] [PubMed]
     [Google Scholar]
  10. Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 1992; 14:83–91 [View Article] [PubMed]
     [Google Scholar]
  11. Farrugia DN, Elbourne LDH, Hassan KA, Eijkelkamp BA, Tetu SG et al. The complete genome and phenome of a community-acquired Acinetobacter baumannii. PLoS One 2013; 8:e58628 [View Article] [PubMed]
     [Google Scholar]
  12. Ong CWM, Lye DCB, Khoo KL, Chua GSW, Yeoh SF et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 2009; 14:1200–1205 [View Article] [PubMed]
     [Google Scholar]
  13. Chen HP, Chen TL, Lai CH, Fung CP, Wong WW et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005; 38:127–136 [PubMed]
     [Google Scholar]
  14. El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A et al. Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections. Antibiotics 2020; 9:E603 [View Article] [PubMed]
     [Google Scholar]
  15. Fairhead L, Vardanega J, Pandey R, Smith S. Polymicrobial community-acquired Acinetobacter baumannii and Burkholderia pseudomallei bacteremia: opportunistic infections with similar risk factors in northern Australia. IDCases 2020; 21:e00833 [View Article] [PubMed]
     [Google Scholar]
  16. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007; 26:857–868 [View Article] [PubMed]
     [Google Scholar]
  17. Zeana C, Larson E, Sahni J, Bayuga SJ, Wu F et al. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir?. Infect Control Hosp Epidemiol 2003; 24:275–279 [View Article] [PubMed]
     [Google Scholar]
  18. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009; 73:355–363 [View Article] [PubMed]
     [Google Scholar]
  19. Eveillard M, Kempf M, Belmonte O, Pailhoriès H, Joly-Guillou M-L. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis 2013; 17:e802–5 [View Article] [PubMed]
     [Google Scholar]
  20. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939–951 [View Article] [PubMed]
     [Google Scholar]
  21. Berlau J, Aucken HM, Houang E, Pitt TL. Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect 1999; 42:201–204 [View Article] [PubMed]
     [Google Scholar]
  22. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol 2001; 39:228–234 [View Article]
     [Google Scholar]
  23. Scott P, Deye G, Srinivasan A, Murray C, Moran K et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44:1577–1584 [View Article] [PubMed]
     [Google Scholar]
  24. Vangnai AS, Petchkroh W. Biodegradation of 4-chloroaniline by bacteria enriched from soil. FEMS Microbiol Lett 2007; 268:209–216 [View Article] [PubMed]
     [Google Scholar]
  25. Choi J-Y, Kim Y, Ko EA, Park YK, Jheong W-H et al. Acinetobacter species isolates from a range of environments: species survey and observations of antimicrobial resistance. Diagn Microbiol Infect Dis 2012; 74:177–180 [View Article] [PubMed]
     [Google Scholar]
  26. Anane A Y, Apalata T, Vasaikar S, Okuthe GE, Songca S. Prevalence and molecular analysis of multidrug-resistant Acinetobacter baumannii in the extra-hospital environment in Mthatha, South Africa. Braz J Infect Dis 2019; 23:371–380 [View Article] [PubMed]
     [Google Scholar]
  27. Minard G, Tran FH, Raharimalala FN, Hellard E, Ravelonandro P et al. Prevalence, genomic and metabolic profiles of Acinetobacter and Asaia associated with field-caught Aedes albopictus from Madagascar. FEMS Microbiol Ecol 2013; 83:63–73 [View Article] [PubMed]
     [Google Scholar]
  28. Ghai R, Rodriguez-Valera F, McMahon KD, Toyama D, Rinke R et al. Metagenomics of the water column in the pristine upper course of the Amazon river. PLoS One 2011; 6:e23785 [View Article] [PubMed]
     [Google Scholar]
  29. Byrne-Bailey KG, Gaze WH, Kay P, Boxall ABA, Hawkey PM et al. Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom. Antimicrob Agents Chemother 2009; 53:696–702 [View Article] [PubMed]
     [Google Scholar]
  30. Hamouda A, Findlay J, Al Hassan L, Amyes SGB. Epidemiology of Acinetobacter baumannii of animal origin. Int J Antimicrob Agents 2011; 38:314–318 [View Article] [PubMed]
     [Google Scholar]
  31. Hernández-González IL, Castillo-Ramírez S. Antibiotic-resistant Acinetobacter baumannii is a One Health problem. The Lancet Microbe 2020; 1:e279 [View Article]
     [Google Scholar]
  32. Geisinger E, Mortman NJ, Vargas-Cuebas G, Tai AK, Isberg RR. A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog 2018; 14:e1007030 [View Article] [PubMed]
     [Google Scholar]
  33. Gebhardt MJ, Shuman HA. GigA and GigB are master regulators of antibiotic resistance, stress responses, and virulence in Acinetobacter baumannii. J Bacteriol 2017; 199:10 [View Article] [PubMed]
     [Google Scholar]
  34. Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018; 16:91–102 [View Article] [PubMed]
     [Google Scholar]
  35. Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 2012; 10:525–537 [View Article] [PubMed]
     [Google Scholar]
  36. Gayoso CM, Mateos J, Méndez JA, Fernández-Puente P, Rumbo C et al. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res 2014; 13:460–476 [View Article] [PubMed]
     [Google Scholar]
  37. Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H et al. Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T. Microbiology (Reading) 2004; 150:2587–2597 [View Article] [PubMed]
     [Google Scholar]
  38. Antunes LCS, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 2014; 71:292–301 [View Article] [PubMed]
     [Google Scholar]
  39. Cerqueira GM, Kostoulias X, Khoo C, Aibinu I, Qu Y et al. A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. J Infect Dis 2014; 210:46–55 [View Article] [PubMed]
     [Google Scholar]
  40. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article] [PubMed]
     [Google Scholar]
  41. Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011; 6:407–422 [View Article] [PubMed]
     [Google Scholar]
  42. Giannouli M, Antunes LCS, Marchetti V, Triassi M, Visca P et al. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis 2013; 13:282 [View Article] [PubMed]
     [Google Scholar]
  43. Fournier P-E, Vallenet D, Barbe V, Audic S, Ogata H et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2:e7 [View Article] [PubMed]
     [Google Scholar]
  44. Repizo GD, Espariz M, Seravalle JL, Díaz Miloslavich JI, Steimbrüch BA et al. Acinetobacter baumannii NCIMB8209: a rare environmental strain displaying extensive insertion sequence-mediated genome remodeling resulting in the loss of exposed cell structures and defensive mechanisms. mSphere 2020; 5:e00404-20 [View Article] [PubMed]
     [Google Scholar]
  45. Girlich D, Poirel L, Nordmann P. First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrob Agents Chemother 2010; 54:578–579 [View Article] [PubMed]
     [Google Scholar]
  46. Suihko M-L, Skyttä E. Characterisation of aerobically grown non-spore-forming bacteria from paper mill pulps containing recycled fibres. J Ind Microbiol Biotechnol 2009; 36:53–64 [View Article] [PubMed]
     [Google Scholar]
  47. Rafei R, Hamze M, Pailhoriès H, Eveillard M, Marsollier L et al. Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. Appl Environ Microbiol 2015; 81:2359–2367 [View Article] [PubMed]
     [Google Scholar]
  48. Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res 2015; 25:1043–1055 [View Article] [PubMed]
     [Google Scholar]
  49. Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 2016; 44:6614–6624 [View Article] [PubMed]
     [Google Scholar]
  50. Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom 2020;6. 10.1099/mgen.0.000339. [PubMed]
  51. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article] [PubMed]
     [Google Scholar]
  52. Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics 2019; 35:4453–4455 [View Article] [PubMed]
     [Google Scholar]
  53. Arndt D, Grant JR, Marcu A, Sajed T, Pon A et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 2016; 44:W16–21 [View Article] [PubMed]
     [Google Scholar]
  54. Bell SM, Smith DD. The CDS Disc Method of Antibiotic Sensitivity Testing (Calibrated Dichotomous Sensitivity Test). Pathology 1975; 7:1–48 [View Article]
     [Google Scholar]
  55. Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008; 3:163–175 [View Article] [PubMed]
     [Google Scholar]
  56. CLSI Performance Standards for Antimicrobial Susceptibility Testing; 29th Informational Supplement Wayne, PA: Clinical and Laboratory Standards Institute; 2019
     [Google Scholar]
  57. EUCAST The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0; 2021 http://www.eucast.org
  58. O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp 2011; 2011:47 [View Article] [PubMed]
     [Google Scholar]
  59. Kon H, Schwartz D, Temkin E, Carmeli Y, Lellouche J. Rapid identification of capsulated Acinetobacter baumannii using a density-dependent gradient test. BMC Microbiol 2020; 20:285 [View Article] [PubMed]
     [Google Scholar]
  60. Frei A, King AP, Lowe GJ, Cain AK, Short FL et al. Nontoxic Cobalt(III) Schiff Base Complexes with Broad-Spectrum Antifungal Activity. Chemistry 2021; 27:2021–2029 [View Article] [PubMed]
     [Google Scholar]
  61. Loh JMS, Adenwalla N, Wiles S, Proft T. Galleria mellonella larvae as an infection model for group A streptococcus. Virulence 2013; 4:419–428 [View Article] [PubMed]
     [Google Scholar]
  62. Mackie AM, Hassan KA, Paulsen IT, Tetu SG. Biolog Phenotype Microarrays for phenotypic characterization of microbial cells. Methods Mol Biol 2014; 1096:123–130 [View Article] [PubMed]
     [Google Scholar]
  63. Koong J, Johnson C, Rafei R, Hamze M, Myers GSA et al. Phylogenomics of two ST1 antibiotic-susceptible non-clinical Acinetobacter baumannii strains reveals multiple lineages and complex evolutionary history in global clone 1. Microb Genom 2021; 7: [View Article]
     [Google Scholar]
  64. Repizo GD, Viale AM, Borges V, Cameranesi MM, Taib N et al. The Environmental Acinetobacter baumannii Isolate DSM30011 Reveals Clues into the Preantibiotic Era Genome Diversity, Virulence Potential, and Niche Range of a Predominant Nosocomial Pathogen. Genome Biol Evol 2017; 9:2292–2307 [View Article] [PubMed]
     [Google Scholar]
  65. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008; 190:8053–8064 [View Article] [PubMed]
     [Google Scholar]
  66. Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S et al. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One 2008; 3:e1805 [View Article] [PubMed]
     [Google Scholar]
  67. Héritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006; 12:123–130 [View Article] [PubMed]
     [Google Scholar]
  68. Hamidian M, Nigro SJ, Hall RM. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother 2012; 67:2833–2836 [View Article] [PubMed]
     [Google Scholar]
  69. Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol 2010; 48:1223–1230 [View Article] [PubMed]
     [Google Scholar]
  70. Gaiarsa S, Batisti Biffignandi G, Esposito EP, Castelli M, Jolley KA et al. Comparative analysis of the two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes. Front Microbiol 2019; 10:930 [View Article] [PubMed]
     [Google Scholar]
  71. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr et al. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53:2605–2609 [View Article] [PubMed]
     [Google Scholar]
  72. Dinh H, Semenec L, Kumar SS, Short FL, Cain AK. Microbiology’s next top model: Galleria in the molecular age. Pathog Dis 2021; 79:ftab006 [View Article] [PubMed]
     [Google Scholar]
  73. Fiester SE, Actis LA. Stress responses in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol 2013; 8:353–365 [View Article] [PubMed]
     [Google Scholar]
  74. Palmer LD, Skaar EP. Transition metals and virulence in bacteria. Annu Rev Genet 2016; 50:67–91 [View Article] [PubMed]
     [Google Scholar]
  75. Palmer LD, Jordan AT, Maloney KN, Farrow MA, Gutierrez DB et al. Zinc intoxication induces ferroptosis in A549 human lung cells. Metallomics 2019; 11:982–993 [View Article] [PubMed]
     [Google Scholar]
  76. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. PHAST: a fast phage search tool. Nucleic Acids Res 2011; 39:W347–52 [View Article] [PubMed]
     [Google Scholar]
  77. De Gregorio E, Del Franco M, Martinucci M, Roscetto E, Zarrilli R et al. Biofilm-associated proteins: news from Acinetobacter. BMC Genomics 2015; 16:933 [View Article] [PubMed]
     [Google Scholar]
  78. Geisinger E, Isberg RR. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog 2015; 11:e1004691 [View Article] [PubMed]
     [Google Scholar]
  79. Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010; 78:3993–4000 [View Article] [PubMed]
     [Google Scholar]
  80. Espinal P, Martí S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 2012; 80:56–60 [View Article] [PubMed]
     [Google Scholar]
  81. Farrow JM, Wells G, Pesci EC. Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR. PLoS One 2018; 13:e0205638 [View Article]
     [Google Scholar]
  82. Boll JM, Tucker AT, Klein DR, Beltran AM, Brodbelt JS et al. Reinforcing Lipid A acylation on the cell surface of Acinetobacter baumannii promotes cationic antimicrobial peptide resistance and desiccation survival. mBio 2015; 6:e00478–15 [View Article]
     [Google Scholar]
  83. García A, Solar H, González C, Zemelman R. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum. J Med Microbiol 2000; 49:1047–1050 [View Article] [PubMed]
     [Google Scholar]
  84. King LB, Swiatlo E, Swiatlo A, McDaniel LS. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol 2009; 55:414–421 [View Article] [PubMed]
     [Google Scholar]
  85. Kim SW, Choi CH, Moon DC, Jin JS, Lee JH et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 2009; 301:224–231 [View Article] [PubMed]
     [Google Scholar]
  86. Medzhitov R, Janeway C. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:89–97 [View Article] [PubMed]
     [Google Scholar]
  87. Coyne S, Rosenfeld N, Lambert T, Courvalin P, Périchon B. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54:4389–4393 [View Article] [PubMed]
     [Google Scholar]
  88. Liu Q, Hassan KA, Ashwood HE, Gamage HKAH, Li L et al. Regulation of the aceI multidrug efflux pump gene in Acinetobacter baumannii. J Antimicrob Chemother 2018; 73:1492–1500 [View Article] [PubMed]
     [Google Scholar]
  89. Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001; 45:3375–3380 [View Article] [PubMed]
     [Google Scholar]
  90. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS et al. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother 2011; 55:3743–3751 [View Article] [PubMed]
     [Google Scholar]
  91. Vila J, Ruiz J, Goñi P, Jimenez de Anta T. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 1997; 39:757–762 [View Article]
     [Google Scholar]
  92. Hamidian M, Hall RM. Acinetobacter baumannii ATCC 19606 Carries gisul2 in a genomic island located in the chromosome. Antimicrob Agents Chemother 2017; 61:e01991-16 [View Article]
     [Google Scholar]
  93. Sánchez-Osuna M, Cortés P, Llagostera M, Barbé J, Erill I. Exploration into the origins and mobilization of di-hydrofolate reductase genes and the emergence of clinical resistance to trimethoprim. Microb Genom 2020; 6:11 [View Article]
     [Google Scholar]
  94. Ambrose SJ, Hall RM. dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering. J Antimicrob Chemother 2021; 76:2748–2756 [View Article] [PubMed]
     [Google Scholar]
  95. Eijkelkamp BA, Hassan KA, Paulsen IT, Brown MH. Development of a high-throughput cloning strategy for characterization of acinetobacter baumannii drug transporter proteins. J Mol Microbiol Biotechnol 2011; 20:211–219 [View Article]
     [Google Scholar]
  96. Hassan KA, Brzoska AJ, Wilson NL, Eijkelkamp BA, Brown MH et al. Roles of DHA2 family transporters in drug resistance and iron homeostasis in Acinetobacter spp. J Mol Microbiol Biotechnol 2011; 20:116–124 [View Article] [PubMed]
     [Google Scholar]
  97. Hrenovic J, Durn G, Goic-Barisic I, Kovacic A. Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia. Appl Environ Microbiol 2014; 80:2860–2866 [View Article] [PubMed]
     [Google Scholar]
  98. Nie D, Hu Y, Chen Z, Li M, Hou Z et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci 2020; 27:26 [View Article] [PubMed]
     [Google Scholar]
  99. Gallagher LA, Ramage E, Weiss EJ, Radey M, Hayden HS et al. Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii. J Bacteriol 2015; 197:2027–2035 [View Article] [PubMed]
     [Google Scholar]
  100. Boinett CJ, Cain AK, Hawkey J, Do Hoang NT, Khanh NNT et al. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii. Microb Genom 2019; 5: [View Article] [PubMed]
     [Google Scholar]
  101. Baumann P, Doudoroff M, Stanier RY. A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter). J Bacteriol 1968; 95:1520–1541 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000765
Loading
Genomic and phenotypic analyses of diverse non-clinical Acinetobacter baumannii strains reveals strain-specific virulence and resistance capacity
M Gen 8, 000765 (2022); https://doi.org/10.1099/mgen.0.000765
/content/journal/mgen/10.1099/mgen.0.000765
/content/journal/mgen/10.1099/mgen.0.000765
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error